Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 4 | |
Outperform | 10 | |
Hold | 16 | |
Sell | 1 | |
Strong Sell | 0 |
Share price forecast in USD
The 26 analysts offering 12 month price targets for Gilead Sciences, Inc. have a median target of 79.50, with a high estimate of 119.00 and a low estimate of 68.50. The median estimate represents a -4.27% decrease from the last price of 83.05.
High | 41.9% | 119.00 |
Med | -5.2% | 79.50 |
Low | -18.3% | 68.50 |
Dividends in USD
Div growth (TTM) | 2.74% |
---|
More ▼
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 07, 2024.
Average growth rate | +23.00% |
Average growth rate | +0.48% |
More ▼
Revenue history & estimates in USD
Average growth rate | +1.43% |
Average growth rate | +4.97% |
More ▼